Idexx Laboratories Inc (IDXX) Stock Price

IDXXStock

$550.01−13.33%52W

Market Cap$43.33B

P/E41.95x

PEG Ratio3.41

Div yield—

Beta1.56

IDXX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-23.12%

Price vs S&P 500 (4W)-4.81%

PEG Ratio3.41

VGM Score46.49

P/E Ratio (Annual)41.95x

P/CF (Annual)37.61x

Book Value / Share (Quarterly)$20.45

P/TBV (Annual)36.12x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)8.52%

Cash Flow / Share (Quarterly)$15.68

Price vs S&P 500 (YTD)-29.26%

Gross Margin (TTM)62.45%

Net Profit Margin (TTM)25.03%

EPS (TTM)$14.23

10-Day Avg Trading Volume0.52M

EPS Excl Extra (TTM)$14.23

Revenue Growth (5Y)9.72%

EPS (Annual)$13.08

ROI (Annual)43.19%

Gross Margin (Annual)61.80%

Net Profit Margin (5Y Avg)22.76%

Cash / Share (Quarterly)$2.50

P/E Basic Excl Extra (TTM)39.00x

Revenue Growth QoQ (YoY)9.66%

EPS Growth (5Y)14.28%

P/E Normalized (Annual)41.95x

ROA (Last FY)31.62%

Revenue Growth TTM (YoY)12.77%

EBITD / Share (TTM)$20.12

ROE (5Y Avg)79.61%

Operating Margin (TTM)32.03%

Cash Flow / Share (Annual)$13.09

P/B Ratio27.56x

P/B Ratio (Quarterly)25.75x

Net Income / Employee (Annual)$96,300

EV / Revenue (TTM)9.93x

Net Interest Coverage (TTM)34.07x

ROA (TTM)33.61%

EPS Growth QoQ (YoY)17.55%

EV / EBITDA (TTM)28.04x

EPS Incl Extra (Annual)$13.08

Current Ratio (Annual)1.23x

Quick Ratio (Quarterly)0.82x

3-Month Avg Trading Volume0.64M

52-Week Price Return-13.33%

EV / Free Cash Flow (Annual)43.33x

P/E Incl Extra (TTM)39.00x

Revenue / Employee (TTM)$413,900

Tangible BV / Share (Quarterly)$19.20

P/S Ratio (Annual)10.33x

Asset Turnover (Annual)1.28x

52-Week High$769.98

Operating Margin (5Y Avg)29.24%

EPS Excl Extra (Annual)$13.08

CapEx CAGR (5Y)5.08%

Tangible BV CAGR (5Y)20.88%

26-Week Price Return-11.87%

Quick Ratio (Annual)0.85x

13-Week Price Return1.16%

Total Debt / Equity (Annual)0.53x

Current Ratio (Quarterly)1.17x

Enterprise Value$45.21B

Revenue / Share Growth (5Y)11.22%

Asset Turnover (TTM)1.34x

Book Value / Share Growth (5Y)22.18%

Revenue / Employee (Annual)$391,200

Inventory Turnover (Annual)4.33x

Pretax Margin (Annual)30.77%

Cash / Share (Annual)$2.26

3-Month Return Std Dev31.62%

Gross Margin (5Y Avg)60.19%

Net Income / Employee (TTM)$103,600

EBITDA CAGR (5Y)13.75%

EBITDA Interim CAGR (5Y)10.39%

ROE (Last FY)65.99%

Net Interest Coverage (Annual)42.67x

EPS Basic Excl Extra (Annual)$13.08

P/FCF (TTM)35.93x

Receivables Turnover (TTM)6.81x

EV / Free Cash Flow (TTM)36.55x

Total Debt / Equity (Quarterly)0.60x

EPS Incl Extra (TTM)$14.23

Receivables Turnover (Annual)7.40x

ROI (TTM)45.08%

P/S Ratio (TTM)9.76x

Pretax Margin (5Y Avg)28.37%

Revenue / Share (Annual)$53.12

Tangible BV / Share (Annual)$18.76

Forward P/E35.55x

Free OCF CAGR (5Y)14.08%

Price vs S&P 500 (52W)-31.64%

P/E Ratio (TTM)39.00x

EPS Growth TTM (YoY)18.43%

Year-to-Date Return-17.30%

5-Day Price Return1.12%

EPS Normalized (Annual)$13.08

ROA (5Y Avg)27.96%

Net Profit Margin (Annual)24.62%

Month-to-Date Return0.08%

Cash Flow / Share (TTM)$11.16

EBITD / Share (Annual)$18.58

EPS Growth (3Y)17.66%

Operating Margin (Annual)31.60%

LT Debt / Equity (Annual)0.23x

P/CF (TTM)32.40x

ROI (5Y Avg)38.97%

P/E Excl Extra (TTM)39.00x

LT Debt / Equity (Quarterly)0.19x

EPS Basic Excl Extra (TTM)$14.23

P/TBV (Quarterly)27.42x

P/B Ratio (Annual)33.65x

Inventory Turnover (TTM)4.36x

Pretax Margin (TTM)31.28%

Book Value / Share (Annual)$20.14

Price vs S&P 500 (13W)-1.63%

Net Margin Growth (5Y)2.76%

Beta1.56x

P/FCF (Annual)42.59x

Revenue / Share (TTM)$57.41

ROE (TTM)71.96%

52-Week Low$518.55

vGradeD

gGradeB

mGradeC

vgmGradeC

IDXX Earnings Surprise History

Q2 253.63est. 3.30

Q3 253.40est. 3.15

Q4 253.08est. 2.94

Q1 263.47est. 3.41

Q2 264.27est. 3.93

IDXX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.96

3.95

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
NEOGNeogen Corp	C	C	B	$11.64
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
TRIBTrinity Biotech plc	B	D	F	$9.71
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About Idexx Laboratories Inc

IDEXX Laboratories is a leading provider of diagnostic solutions and practice management software for veterinary and livestock producers. The company offers in-clinic diagnostic test kits, laboratory analyzers, reference laboratory services, and veterinary practice management software that enable disease detection and management. With approximately 35% of revenues derived outside the United States, IDEXX operates across both domestic and international veterinary markets.